Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction

  • Austin P
  • Tu J
  • Ko D
 et al. 
  • 1


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


BACKGROUND: In an accompanying article, we report moderate between-hospital variation in the postdischarge use of beta-blockers, angiotensin-modifying drugs and statins by elderly patients who had been admitted to hospital with acute myocardial infarction. Our objective was to identify the characteristics of patients, physicians, hospitals and communities associated with differences in the use of these medications after discharge. METHODS: For this retrospective, population-based cohort study, we used linked administrative databases. We examined data for all patients aged 65 years or older who were discharged from hospital in 2005/06 with a diagnosis of myocardial infarction. We determined the effect of patient, physician, hospital and community characteristics on the rate of postdischarge medication use. RESULTS: Increasing patient age was associated with lower postdischarge use of medications. The odds ratios (ORs) for a 1-year increase in age were 0.98 (95% confidence interval [CI] 0.97-0.99) for beta-blockers, 0.97 (95% CI 0.97-0.98) for angiotensin-converting-enzyme inhibitors and angiotensin-receptor blockers and 0.94 (95% CI 0.93-0.95) for statins. Having a general or family practitioner, a general internist or a physician of another specialty as the attending physician, relative to having a cardiologist, was associated with lower postdischarge use of beta-blockers, angiotensin-modifying agents and statins (ORs ranging from 0.46 to 0.82). Having an attending physician with 29 or more years experience, relative to having a physician who had graduated within the past 15 years, was associated with lower use of beta-blockers (OR 0.71, 95% CI 0.60-0.84) and statins (OR 0.81, 95% CI 0.67-0.97). INTERPRETATION: Patients who received care from noncardiologists and physicians with at least 29 years of experience had substantially lower use of evidence-based drug therapies after discharge. Dissemination strategies should be devised to improve the prescribing of evidence-based medications by these physicians

Author-supplied keywords

  • ACE-I#
  • Adrenergic beta-Antagonists
  • Aged
  • Aged,80 and over
  • Angiotensin II Type 1 Receptor Blockers
  • Care
  • Cohort Studies
  • Community
  • Data
  • Databases
  • Drug Prescriptions
  • Drugs
  • Elderly
  • Evidence-Based Medicine
  • Family
  • Female
  • Follow-Up Studies
  • Hospital
  • Hospitals
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Male
  • Myocardial Infarction
  • Odds Ratio
  • Patient Discharge
  • Patients
  • Physician-Patient Relations
  • Physicians
  • Prescribing
  • Report
  • Retrospective Studies
  • Treatment Outcome
  • WHO
  • acute
  • acute myocardial infarction
  • age
  • article
  • associated
  • beta-blocker#
  • cohort
  • cohort study
  • communities
  • confidence interval
  • diagnosis
  • drug therapy
  • effect
  • factors
  • infarction
  • medication
  • method
  • methods
  • myocardial
  • older
  • patient
  • relative
  • results
  • risk factor#
  • statin#
  • therapy

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Peter C Austin

  • Jack V Tu

  • Dennis T Ko

  • David A Alter

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free